King George III and porphyria: an elemental hypothesis and investigation

  title={King George III and porphyria: an elemental hypothesis and investigation},
  author={Timothy M. Cox and Nicola Jack and Simon D. Lofthouse and John R. Watling and Janice Haines and Martin J. Warren},
  journal={The Lancet},

Figures from this paper

King George III and porphyria: a clinical re-examination of the historical evidence

Re-examination of the evidence suggests it is unlikely that he had porphyria, and claims about peripheral neuropathy, cataracts, vocal hoarseness and abdominal pains are re-evaluated.

A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the ‘Royal Malady’

It is concluded that neither George nor his relatives had porphyria, based on four principal reasons: the rarity of the disease mandates a very low prior probability, and therefore implies a vanishingly low positive predictive value for any diagnostic indicator of low specificity.

Porphyria cutanea tarda: an intriguing genetic disease and marker

The diagnosis of pseudoporphyria, which does not result from enzymatic absence, must be considered in patients with photosensitivity and cutaneous bullae, which is a serious condition in which accurate diagnosis is necessary for appropriate management.

Henry VIII, McLeod syndrome and Jacquetta's curse.

A critically review of the coexistence of both Kell blood group antigenicity and McLeod syndrome for Henry VIII, examining in detail the pathophysiology of these conditions and assessing the genealogy of Henry VIII and its effect in subsequent generations.

The nature of King James VI/I’s medical conditions: new approaches to the diagnosis

It has been claimed that King James VI/I, an antecedent of King George III, suffered from acute porphyria, and that the disease was passed on to George III through his grand-daughter Sophie, mother

Computer-based diagnosis of illness in historical persons.

  • T. Peters
  • Psychology
    The journal of the Royal College of Physicians of Edinburgh
  • 2013
Modern technology has been used to strengthen the findings of previous reports rejecting the popular diagnosis of variegate porphyria in the King, his grandson Augustus d'Esté and his antecedent King James VI and I.



Porphyria in the royal houses of Stuart, Hanover, and Prussia. A follow-up study of George 3d's illness.

His illness had traditionally been called manic-depressive psychosis simply because it came in attacks during which he was excited, but this diagnosis did not account for the fact that he was first deranged in his severest attack at the age of 50 in 1788.

Variegate porphyria and heavy metal poisoning from ingestion of "moonshine".

In a patient with disorientation, bullous skin lesions, and a history of illicit alcohol ingestion, one must consider heavy metal intoxication and secondary porphyrin abnormalities.

The "insanity" of King George 3d: a classic case of porphyria.

The royal malady influenced the history of psychiatry, not least by dragging the " mad-business " into the limelight (Hunter and Macalpine, 1963), but only two clinical studies have been devoted to it.

Porphyrins as early biomarkers for arsenic exposure in animals and humans.

A positive correlation between the urinary arsenic levels and porphyrin concentrations demonstrated the effect of arsenic on haem biosynthesis, and significant alteration in the p Morphyrin excretion profiles of the younger age (<20 y) arsenic exposed group suggested that porphyrs could be used as early warning biomarkers for chronic exposure to arsenic.

Arsenic and porphyrins.

The increase of urinary excretion for some porphyrin homologues appears to be consistent with the inhibition by As of URO-decarboxylase in the heme biosynthesis pathway.

The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001

  • C. Scriver
  • Chemistry
    Journal of Inherited Metabolic Disease
  • 2004

Disorders of Heme Biosynthesis

X-linked sideroblastic anemia is due to a deficiency of the erythroid form of the first enzyme in the heme biosynthetic pathway, 5-aminolevulinic acid synthase. Characteristics of the disease are

Acute and chronic arsenic toxicity

There are no evidence based treatment regimens to treat chronic arsenic poisoning but antioxidants have been advocated, though benefit is not proven, and there is increasing emphasis on using alternative supplies of water.

Clinical and environmental aspects of arsenic toxicity.

Small amounts of arsenic are metabolized in a variety of ways and are largely rapidly methylated and excreted by man and animals, and toxic manifestations in man occur at the cellular level and may appear in many organ systems.